291 related articles for article (PubMed ID: 21725199)
1. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
[TBL] [Abstract][Full Text] [Related]
3. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
Naito T; Yuge R; Kitadai Y; Takigawa H; Higashi Y; Kuwai T; Kuraoka K; Tanaka S; Chayama K
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907853
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
[TBL] [Abstract][Full Text] [Related]
6. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
[TBL] [Abstract][Full Text] [Related]
7. Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
Schweiger T; Nikolowsky C; Starlinger P; Traxler D; Zimmermann M; Birner P; Hegedüs B; Dome B; Bergmann M; Mildner M; Klepetko W; Hoetzenecker K; Ankersmit HJ
PLoS One; 2015; 10(3):e0120724. PubMed ID: 25793600
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the ITGAV gene is associated with progression and spread of colorectal cancer.
Waisberg J; De Souza Viana L; Affonso Junior RJ; Silva SR; Denadai MV; Margeotto FB; De Souza CS; Matos D
Anticancer Res; 2014 Oct; 34(10):5599-607. PubMed ID: 25275062
[TBL] [Abstract][Full Text] [Related]
9. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
10. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic changes in tumor microenvironment.
Dey P
Indian J Cancer; 2011; 48(4):507-12. PubMed ID: 22293269
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
13. SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.
Haber CL; Gottifredi V; Llera AS; Salvatierra E; Prada F; Alonso L; Sage EH; Podhajcer OL
Int J Cancer; 2008 Apr; 122(7):1465-75. PubMed ID: 18059024
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
15. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
[TBL] [Abstract][Full Text] [Related]
17. In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression.
Kim NI; Kim GE; Lee JS; Park MH
Virchows Arch; 2017 Jan; 470(1):91-98. PubMed ID: 27909812
[TBL] [Abstract][Full Text] [Related]
18. Role of secreted protein acidic in hematogenous metastasis of gastric cancer.
Mo A; Yang SW; Jiang YX; Zhao YL; Shi Y; Qian F; Hao YX; Yu PW
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4311-4321. PubMed ID: 29077165
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations.
Jiang HH; Zhang ZY; Wang XY; Tang X; Liu HL; Wang AL; Li HG; Tang EJ; Lin MB
World J Gastroenterol; 2019 May; 25(20):2489-2502. PubMed ID: 31171892
[TBL] [Abstract][Full Text] [Related]
20. Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.
Paley PJ; Goff BA; Gown AM; Greer BE; Sage EH
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):336-41. PubMed ID: 10985890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
